The science is clear: Allulose is more than just a sugar alternativeits a metabolic ally
Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Dose adjustment is probably not needed for the use of acetaminophen in patients treated with GLP1RAs
Although experience with GLP-1 agonists in patients with obesity and inflammatory skin diseases is currently scarce, the promising results reported suggest they may offer a useful tool for managing obesity
Weight loss injections like Saxenda (liraglutide) have surged in popularity all over the county, which is no surprise given the obesity epidemic in America
Similarly, another study found a higher rate of progression of proliferative diabetic retinopathy as well as risk of new-onset diabetic macular edema with GLP-1 RAs compared to SGLT-2is